Ardelyx Inc

Market cap: $1,486,863,591

Exchange: NAS

Sector: Health Technology

Share
Tweet

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.

Key Statistics

Company Name

Ardelyx Inc

Average Volume (10 days)

4,434,265

Average Volume (30 days)

5,180,510

Moving Average (50 days)

$7.54

Moving Average (200 days)

$6.63

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

1,486,863,591

Shares Outstanding

232,686,008

52-Week High Split Adjust Only

10.13

52-Week Low Split Adjust Only

3.16

Employee Count

200

Beta

1.3995

Next Earnings Date

2024-05-02

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.05%

Past 30 days

-0.17%

Past 3 months

-0.26%

Past 6 months

0.85%

Past year

0.29%

Past 2 years

7.54%

Past 5 years

0.81%

Max % Change

-0.55%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Ardelyx IncARDXn/an/a-5.1n/an/a
Peer AvgN/A4.156.8813.94.154.54
Astrazeneca plc - ADRAZN5.4010.33n/a5.405.85
Abbott LaboratoriesABT5.556.1823.15.555.82
AMGEN Inc.AMGN5.4314.6514.65.436.31
Sanofi - ADRSNY2.931.74n/a2.933.17
Opko Health IncOPK1.451.5131.81.451.54